Letter for Disablity 2

July 31, 2007

Re: Carmela Stewart

To Whom It May Concern:

This is to inform you that Carmela Stewart has been ill for some time with chronic persistent Borreliosis and a co-infection, Babesiosis. On August 6, 2007, I confirmed the diagnosis made by another doctor. For more than five years, Ms. Stewart has been experiencing body aches, chills, malaise and fatigue, and in the last six months, joint pain.

I am extremely concerned that a stressful schedule, will not allow her the necessary rest periods for the healing process to proceed adequately. A leave of absence from her job for a minimum of six weeks is advisable.

A Western blot from Igenex Laboratories was IgG positive for bands 31, 41, and 58; IgM positive for bands 18, 30, 39 and showed reactivity on bands 23-25, 34, and 41.

Since her symptoms indicate that the disease is in its later stages, aggressive treatment with intravenous antibiotics is necessary. A recent 3 year NIH study submitted for publication by Dr. Brian A. Fallon of Columbia University, and presented in 2005 at the 10th International Lyme Conference in Vienna, Austria, and at the Lyme Disease Association (LDA) Conference in 2006, showed a strong clinical evidence for the extended intravenous antibiotic therapy (past 4 weeks) in the treatment of chronic relapsing Lyme disease. Therefore, I am recommending the following treatment protocol:

  • PICC line insertion
  • IV Rocephin 2g daily for a minimum of 12 weeks
  • Weekly blood draw—CBC with differential, CMP and Hepatic Function Panel

In 15 years of experience treating patients with chronic Lyme disease, I have witnessed dramatic improvement in response to extended intravenous antibiotic therapy.

If you have any further questions regarding Ms. Stewart, please contact my office.



Bernard D. Raxlen